webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

1-BOC-Azetidine-3-carboxylic acid methyl ester

  CAS No.: 610791-05-4   Cat No.: BADC-01925   Purity: >95% 4.5  

1-BOC-Azetidine-3-carboxylic acid methyl ester is a non-cleavable ADC linker and also an alkyl chain-based PROTAC linker.

1-BOC-Azetidine-3-carboxylic acid methyl ester

Structure of 610791-05-4

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C10H17NO4
Molecular Weight
215.25

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Methyl 1-Boc-azetidine-3-carboxylate; 1-tert-butyl 3-methyl azetidine-1,3-dicarboxylate
IUPAC Name
1-O-tert-butyl 3-O-methyl azetidine-1,3-dicarboxylate
Canonical SMILES
CC(C)(C)OC(=O)N1CC(C1)C(=O)OC
InChI
InChI=1S/C10H17NO4/c1-10(2,3)15-9(13)11-5-7(6-11)8(12)14-4/h7H,5-6H2,1-4H3
InChIKey
SECFRXGVLMVUPD-UHFFFAOYSA-N
Density
1.2±0.1 g/cm3
Boiling Point
269.0±33.0 °C at 760 mmHg

1-BOC-Azetidine-3-carboxylic acid methyl ester, a widely utilized chemical intermediate in organic synthesis and drug development, possesses diverse applications. Here are four key applications articulated with heightened perplexity and burstiness:

Pharmaceutical Development: Playing a pivotal role in drug synthesis, this compound acts as a fundamental building block for an array of pharmaceuticals. Researchers harness its potential to innovate new medications by crafting intricate molecular architectures with tailored therapeutic actions. The protective BOC group it offers aids in orchestrating reaction pathways, ensuring the stability of intermediate compounds, and guiding the synthesis towards desired outcomes.

Peptide Synthesis: A cornerstone in peptide assembly, 1-BOC-Azetidine-3-carboxylic acid methyl ester functions as a strategic component in constructing peptide sequences as a shielded amino acid derivative. Its efficacy lies in fostering the formation of peptide bonds without interfering with other reactive sites within the molecule. This attribute renders it invaluable for assembling peptide chains with meticulous precision and unblemished purity, elevating the realm of peptide synthesis to new heights of precision and efficacy.

Medicinal Chemistry: Within the domain of medicinal chemistry, this compound serves as a potent tool for incorporating azetidine ring motifs into drug candidates. The introduction of azetidine moieties can significantly augment the pharmacokinetic and pharmacodynamic profiles of drugs, enhancing their potency and sustainability. This transformative alteration can pave the way for the development of novel therapeutic agents with heightened effectiveness and therapeutic potential, reshaping the landscape of medicinal chemistry through innovative pharmacological design.

Chemical Research: Proving indispensable in diverse chemical research pursuits, 1-BOC-Azetidine-3-carboxylic acid methyl ester is a catalyst for exploring reaction mechanisms and pioneering novel synthetic methodologies. Its distinct molecular structure empowers chemists to venture into uncharted territories of chemical reactions and transformations, driving forward the frontiers of synthetic organic chemistry and fostering a culture of innovation and discovery at the forefront of chemical research.

1.HMG-CoA reductase inhibitory activity and phytocomponent investigation of Basella alba leaf extract as a treatment for hypercholesterolemia.
Baskaran G1, Salvamani S1, Ahmad SA1, Shaharuddin NA1, Pattiram PD2, Shukor MY1. Drug Des Devel Ther. 2015 Jan 14;9:509-17. doi: 10.2147/DDDT.S75056. eCollection 2015.
The enzyme 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase is the key enzyme of the mevalonate pathway that produces cholesterol. Inhibition of HMG-CoA reductase reduces cholesterol biosynthesis in the liver. Synthetic drugs, statins, are commonly used for the treatment of hypercholesterolemia. Due to the side effects of statins, natural HMG-CoA reductase inhibitors of plant origin are needed. In this study, 25 medicinal plant methanol extracts were screened for anti-HMG-CoA reductase activity. Basella alba leaf extract showed the highest inhibitory effect at about 74%. Thus, B. alba was examined in order to investigate its phytochemical components. Gas chromatography with tandem mass spectrometry and reversed phase high-performance liquid chromatography analysis revealed the presence of phenol 2,6-bis(1,1-dimethylethyl), 1-heptatriacotanol, oleic acid, eicosyl ester, naringin, apigenin, luteolin, ascorbic acid, and α-tocopherol, which have been reported to possess antihypercholesterolemic effects.
2.[GC-MS analysis of the fatty components of pollen Typhae before and after being carbonized].
Ma HF1, Liu B, Zhang GY, Shi RB, Ma CH, Yu MM. Zhongguo Zhong Yao Za Zhi. 2006 Feb;31(3):200-2.
OBJECTIVE: To study the changes of the fatty components of Pollen Typhae before and after being carbonized.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: 1-BOC-Azetidine-3-carboxylic acid methyl ester
Send Inquiry
Verification code
Inquiry Basket